ASX gets smacked by Wall Street sell-off, MinRes tumbles after haul road drama, and all eyes now on the Fed's next move.

Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.

European Lithium has unveiled historical high-grade drill intersections that underscore the potential to grow mineralisation ...

Almonty Industries has continued its strong run, securing a strategic partnership agreement for its tungsten concentrate with ...

Royal Flying Doctor Service paramedics have successfully tested Emvision's portable stroke detector, First Responder.

The ASX was trading amid volatility this morning, swinging between modest gains and losses as Wall Street’s nerves set off a ...

ASX pharmaceutical companies are retaining their assets longer and advancing them to commercialisation in a bid to maximise ...

EMVision's (ASX:EMV) completed further testing of its proof-of-concept First Responder device for traumatic brain and stroke ...

Trigg’s (ASX:TMG) new antimony-gold tenements will be its second exploration asset and will be explored in tandem with Wild ...

Omega Oil and Gas has been judged a speculative buy with a 64c price target by Morgans as it flow tests its Canyon-1H well.

Riversgold is continuing to grow its Northern Zone gold project near Kalgoorlie, striking high grade gold in recent drilling.

Trek Metals is on the hunt for a deposit of major scale at Christmas Creek in the Kimberley, not far south of Halls Creek.